Dinter Elisabeth, Saridaki Theodora, Nippold Markus, Plum Sarah, Diederichs Leonie, Komnig Daniel, Fensky Luisa, May Caroline, Marcus Katrin, Voigt Aaron, Schulz Jörg B, Falkenburger Björn H
Department of Neurology, RWTH University Aachen, Aachen, Germany.
Medizinisches Proteom-Center, Ruhr-Universität Bochum, Bochum, Germany.
J Neurochem. 2016 Sep;138(5):758-74. doi: 10.1111/jnc.13712. Epub 2016 Aug 4.
Parkinson's disease can be caused by mutations in the α-synuclein gene and is characterized by aggregates of α-synuclein protein. Aggregates are degraded by the autophago-lysosomal pathway. Since Rab7 has been shown to regulate trafficking of late endosomes and autophagosomes, we hypothesized that over-expressing Rab7 might be beneficial in Parkinson's disease. To test this hypothesis, we expressed the pathogenic A53T mutant of α-synuclein in HEK293 cells and Drosophila melanogaster. In HEK293 cells, EGFP-Rab7-decorated vesicles contain α-synuclein. Rab7 over-expression reduced the percentage of cells with α-synuclein particles and the amount of α-synuclein protein. Time-lapse microscopy confirmed that particles frequently disappeared with Rab7 over-expression. Clearance of α-synuclein is explained by the increased occurrence of acidified α-synuclein vesicles with Rab7 over-expression, presumably representing autolysosomes. Rab7 over-expression reduced apoptosis and the percentage of dead cells in trypan blue staining. In the fly model, Rab7 rescued the locomotor deficit induced by neuronal expression of A53T-α-synuclein. These beneficial effects were not produced by Rab7 missense mutations causing Charcot Marie Tooth neuropathy, or by the related GTPases Rab5, Rab9, or Rab23. Using mass spectrometry, we identified Rab7 in neuromelanin granules purified from human substantia nigra, indicating that Rab7 might be involved in the biogenesis of these possibly protective, autophagosome-like organelles in dopaminergic neurons. Taken together, Rab7 increased the clearance of α-synuclein aggregates, reduced cell death, and rescued the phenotype in a fly model of Parkinson's disease. These findings indicate that Rab7 is rate-limiting for aggregate clearance, and that Rab7 activation may offer a therapeutic strategy for Parkinson's disease. Cells over-expressing aggregation-prone A53T alpha-synuclein develop cytoplasmic aggregates mimicking changes observed in Parkinson's disease. When following cells in time-lapse microscopy, some few cells are able to remove these aggregates (Opazo et al. 2008). We now show that the percentage of cells clearing all aggregates from their cytosol is greatly increased with Rab7 over-expression, indicating that availability of Rab7 is rate-limiting for autophagic clearance of aggregates. The functional significance of this effect in neurons was confirmed in a Drosophila melanogaster model of Parkinson's disease.
帕金森病可由α-突触核蛋白基因突变引起,其特征是α-突触核蛋白蛋白聚集。聚集体通过自噬-溶酶体途径降解。由于Rab7已被证明可调节晚期内体和自噬体的运输,我们推测过表达Rab7可能对帕金森病有益。为了验证这一假设,我们在人胚肾293细胞(HEK293)和黑腹果蝇中表达了致病性α-突触核蛋白A53T突变体。在HEK293细胞中,带有绿色荧光蛋白(EGFP)标记的Rab7的囊泡含有α-突触核蛋白。Rab7过表达降低了含有α-突触核蛋白颗粒的细胞百分比以及α-突触核蛋白的量。延时显微镜证实,随着Rab7过表达,颗粒经常消失。Rab7过表达导致酸化的α-突触核蛋白囊泡(可能代表自溶酶体)出现增加,这解释了α-突触核蛋白的清除。Rab7过表达减少了细胞凋亡以及台盼蓝染色中死细胞的百分比。在果蝇模型中,Rab7挽救了由A53T-α-突触核蛋白神经元表达诱导的运动功能障碍。导致夏科-马里-图斯病(Charcot Marie Tooth neuropathy)的Rab7错义突变、相关的GTP酶Rab5、Rab9或Rab23并未产生这些有益效果。通过质谱分析,我们在从人黑质中纯化的神经黑色素颗粒中鉴定出Rab7,这表明Rab7可能参与多巴胺能神经元中这些可能具有保护作用的自噬体样细胞器的生物发生。综上所述,Rab7增加了α-突触核蛋白聚集体的清除,减少了细胞死亡,并挽救了帕金森病果蝇模型中的表型。这些发现表明Rab7是聚集体清除的限速因素,并且Rab7激活可能为帕金森病提供一种治疗策略。过表达易聚集的A53Tα-突触核蛋白的细胞会形成模仿帕金森病中观察到变化的细胞质聚集体。在延时显微镜下跟踪细胞时,少数细胞能够清除这些聚集体(奥帕佐等人,2008年)。我们现在表明,随着Rab7过表达,从其细胞质中清除所有聚集体的细胞百分比大大增加,这表明Rab7的可用性是聚集体自噬清除的限速因素。在帕金森病的黑腹果蝇模型中证实了这种作用在神经元中的功能意义。